Emerging trial data indicate that correcting deficiencies in vitamins B, C, D, and E alongside minerals selenium, iron, and zinc can restore mitochondrial homeostasis and blunt inflammageing in older adults. The mechanism centers on these micronutrients acting as essential cofactors for mitochondrial electron transport, antioxidant enzyme systems, and immune resolution pathways. Simultaneously, low EPA and DHA status — common in adults over 60 — amplifies inflammatory signaling; EPA+DHA act synergistically with these micronutrients to contain chronic low-grade inflammation and slow functional decline. Organ deterioration, the paper notes, begins measurably in the fifth decade, making midlife the rational intervention window.
This synthesis, while not a primary trial, carries weight because it articulates a mechanistic framework rarely stated this explicitly in clinical guidance: micronutrients operate as an interdependent biochemical web, not isolated supplements. That framing matters practically — it argues against single-nutrient supplementation strategies and toward composite, personalized repletion guided by biomarker screening from roughly age 40 onward. The overlap with mitochondrial medicine and senolytics research is notable; dysfunctional mitochondria are now recognized as central drivers of the senescence-associated secretory phenotype (SASP), and micronutrient cofactor depletion could be a modifiable upstream trigger. The main limitation is that definitive repletion trials in healthy midlife cohorts remain sparse. This is an expert-consensus framing piece rather than novel trial data — valuable for clinical translation, but causal evidence still awaits larger intervention studies.
